S H Kelkar & Company Ltd
Q4 FY27 Earnings Call Analysis
Chemicals & Petrochemicals
fundraise: No informationcapex: Yesrevenue: Category 3margin: No informationorderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- The company anticipates a near-term increase in debt levels aligned with strategic initiatives and capacity expansion plans.
- Debt is expected to remain range-bound around the current gross debt level of approximately Rs. 800 crore, with a potential variation of +/- Rs. 20-30 crore in the immediate 3 to 6 months.
- No explicit mention of new equity fundraising was made during the transcript.
- Focus will be on capital discipline, tighter capital allocation, and improving working capital efficiency to manage balance sheet strength.
- Investments are ongoing, with committed capex in Europe (EUR 2-3 million in the next 6-12 months) and India (Rs. 70-80 crore in the next 12-18 months), partly funded through debt.
- Management is working on detailed plans for cash flow and debt management, with expectations of positive cash flow from new investments starting in 2-3 years.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Europe: Committed EUR 7-8 million capex, mostly done; expects another EUR 2-3 million outflow in next 6-12 months. New factory expected operational by Q4 FY26, expanding capacity 1.5x from current 90% utilization.
- India: Capex of Rs. 70-80 crore over next 12-18 months focused on rebuilding facilities (Vashivali and Vanavate) post-fire and new expansions; adding 9,000 tons capacity in Q1 FY27 and further 15,000 tons later.
- U.S.: Investment primarily opex for leased manufacturing and creative development centres (~$1.5-2 million invested); expecting $2-2.5 million business by end of next year. Minimal capex as manufacturing is operational lease-based.
- Strategic focus on organic growth in U.S., Europe, and Southeast Asia with enhanced Creative Development Centres (CDCs) to generate new business.
- Overall capex timeline: majority expected to be deployed within 12 to 18 months.
📊revenue
Future growth expectations in sales/revenue/volumes?
- The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year.
- Additional capacity in Southeast Asia (3,600 tons) is expected to add 5-7 million in turnover sales.
- European capacity catering to €50 million is about 90% utilized; plans to increase capacity by 1.5x soon to support aggressive growth in Europe.
- India has current capacity of ~20,000 tons with expansions adding 9,000 tons in Q1 next year and another 15,000 tons thereafter, indicating strong growth headroom.
- Strong double-digit growth is seen in Middle East, Africa, Central Asia, and Southeast Asia markets.
- U.S. market initiatives are beginning to generate orders, with business expected to grow from Q4 this year and into FY '29.
- Growth drivers include new CDCs, operational expansions, and leveraging innovation in emerging markets and smaller clients.
- The company expects to reach double-digit return ratios (~14%) by FY '29, indicating profitable/top-line growth.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28.
- Fragrances EBIT margins projected to improve from current ~8% to 13%-14% over 2-4 years, especially as outside India operations ramp up.
- Blended Fragrances segment EBIT expected around 17%-18%; EBITDA margins are 14%-17%, with EBIT margins 2%-3% higher.
- Overall business EBITDA expected to rise from current 13% to about 17% in next 2 years.
- The company targets a 12% year-on-year revenue CAGR from FY24-25 onwards.
- Return Ratios (ROE/ROCE) currently in single digits (~6%-8%), expected to improve to mid-teens (around 14%) by FY28-FY29.
- New investments and capacity expansions are expected to break-even and contribute positively in 2-3 years.
- Operating leverage and gross margin improvements will drive profitability gains.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The transcript does not provide explicit details about the current or expected order book value.
- However, it mentions that the U.S. Creative Development Centre secured its first customer order, with execution expected from Q4 this year to Q1 next year.
- European business showed 3% YoY growth in euro terms this quarter, indicating healthy demand.
- The company is seeing green shoots and new business opportunities in the U.S., Europe, U.K., Middle East, and Southeast Asia.
- There is some softness in demand in India post-GST changes, but the company expects sales momentum to recover shortly.
- Customer interactions globally are encouraging, especially with smaller brands and e-commerce businesses driving growth.
- Overall, the business pipeline appears promising with a phased build-up over the next 2-3 years as new facilities and markets scale.
